C&EN White Paper
Accelerating multimodal discovery: How to unify data and harmonize workflows across molecular biology and chemistry teams
Brought to you by Sapio Sciences

In this white paper, we provide insights into the challenges and opportunities presented by the explosion in new therapeutic modalities, define the essential lab informatics requirements for multimodal discovery, and present several paths forward for organizations who are developing multimodal candidates in various therapeutic categories.

Key Objectives:

  • How multimodal discovery is impacting scientific informatics requirements
  • Why siloed approaches to multimodal discovery risk the integrity and continuity of multimodal data
  • Three distinct approaches to registering multimodal therapies in your lab informatics ecosystem
  • How to make the right multimodal solution decision for your organization’s requirements
  • What to look for in your unified registry or multimodal platform of choice

Brought to you by:
Sapio Sciences
This content was created by Sapio Sciences, without editorial input from the C&EN Media Group. For more information on C&EN's custom products, visit our C&EN Media Kit.
Please complete the form to download the white paper.
*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

Copyright © 2023 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy